Drug Profile
Research programme: glucose transporter inhibitors - Bayer
Alternative Names: BAY-876Latest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Bayer HealthCare
- Class Pyrazoles; Pyrimidines; Quinolines; Small molecules
- Mechanism of Action Glucose transporter type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 Aug 2023 Discontinued - Preclinical for Cancer in Germany (unspecified route)
- 28 May 2020 No recent reports of development identified for preclinical development in Cancer in Germany
- 16 Apr 2016 Pharmacodynamics data from preclinical trials in Cancer presented at the 107th Annual Meeting of the American Association for Cancer Research (AACR-2016)